A new UK study has highlighted the critical role of GP data in understanding atrial fibrillation (AF), the most common form ...
Baxter International has appointed Brent Shafer, who has been serving as the company’s Lead Independent Director, as Chair ...
NHS England has launched its first-ever breast cancer awareness campaign aimed at highlighting the benefits of screening for ...
Baxter International has appointed Heather Knight, who has been leading the company’s Medical Products and Therapies unit, as Executive Vice President and Chief Operating Officer (COO).
Scientists in Cambridge have developed a new ‘super test’ for prostate cancer to improve screening, diagnosis and ...
The University of Bath has received a £3.5 million Wellcome grant to study cognitive decline and premature brain ageing in ...
Global biotechnology leader CSL has announced that the European Commission (EC) has approved ANDEMBRY (garadacimab), the ...
Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...
Amlenetug received Orphan Drug Designation (ODD) from the US FDA in April 2024, the EMA in May 2021 and SAKIGAKE designation ...
After two years of treatment with bimekizumab, 53.1% of patients experienced mild disease compared to none at baseline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results